Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 3,087 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Guideline Clear all

Conditions: Encopresis, Autism Spectrum Disorder
Interventions: MIE Treatment, Glycerin Suppository, Treatment as Usual (TAU); Behavioral · Drug · Combination Product
Lead sponsor: Emory University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hoarding Disorder
Interventions: Group Cognitive Behavioral Therapy, Peer Facilitated Support Group; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Breast Cancer
Interventions: SIS.NET, Routine Follow-up; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Attitude, Practice Guideline, Breast Cancer
Interventions: read unfavorable article prior to answering questions, read favorable article prior to answering questions; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 39 Years to 49 Years · Female only
Enrollment: 247 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 4
States / cities: Auburn, Massachusetts • Shrewsbury, Massachusetts • Worcester, Massachusetts

Conditions: Heart Failure
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COVID-19, Pneumonia
Interventions: Heparin; Drug
Lead sponsor: University of Manitoba; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 13
States / cities: Atlanta, Georgia • Chicago, Illinois • Jefferson, Louisiana + 10 more

Conditions: Obesity, ESRD
Interventions: Roux-en-y gastric bypass (RYGB); Procedure
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Parkinson Disease
Interventions: IMAGINE-PD, Virtual genetic counseling, Telephone genetic counseling; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years and older
Enrollment: 370 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Lung Cancer
Interventions: Witness Project Lung, General Educational Program; Behavioral
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 50 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Nutley, New Jersey

Conditions: Major Depressive Disorder, Neuroticism, Cognitive Change, Stress
Interventions: Sertraline, bupropion, desvenlafaxine; Drug
Lead sponsor: David Steffens; Other
Eligibility: 65 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Stress Disorders, Post-Traumatic, Anxiety Disorders, Mental Disorder, Traumatic Disorder
Interventions: Prolonged Exposure; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Multiple Sclerosis
Interventions: Resistance exercise, Stretching exercise; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 54 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Urbana-Champaign, Illinois

Conditions: Tobacco Use Cessation
Interventions: Nicotine Patch, Questionnaires, Pamphlet, Phone Counseling Sessions, Saliva Test, Smart phone; Drug · Behavioral · Other + 1 more
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 2 Diabetes Mellitus
Interventions: Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo to ertugliflozin 15 mg, Placebo to ertugliflozin 5 mg, Insulin, Metformin; Drug · Biological
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 10 Years to 17 Years
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 11
States / cities: Birmingham, Alabama • Los Angeles, California • Sacramento, California + 8 more

Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: Customized Sleep Coaching, Sleep Hygiene Training; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm
Interventions: Best Practice, Educational Intervention, Questionnaire Administration, Electronic Health Record Review, Health Telemonitoring, Cancer Pain Management; Other · Procedure · Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 680 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Conditions: Hypoplastic Left Heart Syndrome
Interventions: Ventrix Bio Extracellular Matrix; Drug
Lead sponsor: Emory University; Other
Eligibility: Up to 1 Year
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Leukemia
Interventions: Talazoparib, Decitabine; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Asthma
Interventions: NIOX MINO® Instrument (09-1100); Device
Lead sponsor: Aerocrine AB; Industry
Eligibility: 7 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 8
States / cities: Blue Bell, Pennsylvania • Collegeville, Pennsylvania • Doylestown, Pennsylvania + 5 more

Conditions: Diffuse Large B-Cell Lymphoma
Interventions: ME-401, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone; Drug
Lead sponsor: Deepa Jagadeesh; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Skin Basal Cell Carcinoma
Interventions: Best Practice, Educational Activity, Patient Observation, Survey Administration; Other
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 65 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: IPF, Pulmonary Fibrosis, ILD
Interventions: Sample collection, Questionnaires, High resolution CT scan of the chest, Pulmonary Function Test; Other · Radiation · Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 75 Years
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Tobacco Use Disorder, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: smoking cessation intervention, counseling intervention; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 344 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 5
States / cities: Aurora, Colorado • Honolulu, Hawaii • Boston, Massachusetts + 1 more

Conditions: Psychosis, Substance Use, Substance Use Disorders, Family, Cannabis, Marijuana, Alcohol, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Mental Disorder
Interventions: CRAFT-EP, TAU; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Belmont, Massachusetts

Search by objective public record fields.

Treatment of Encopresis in Children With Autism Spectrum Disorders

Comparison of Treatment for Hoarding Disorder

Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer

Patient Perception of Mammogram Guidelines

Guideline Directed Medical Therapy in Patients With Heart Failure

Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)

Bariatric Surgery for ESRD Patients vs Control

GEnetic Counseling Through Virtual Visits in Parkinson's Disease

Witness Project Lung

Predictors of Cognitive Outcomes in Geriatric Depression

Peer Social Support During In Vivo Exposure for PTSD

Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot Study

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS)

Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts

A Study to Explore the Utility of Fractional Exhaled Nitric Oxide (FeNO) Compared With Methacholine Challenge (MCC) Testing in the Assessment of Patients With Suspected But Undiagnosed Asthma

ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

Advancing Prevention of Pulmonary Fibrosis

Primary Care Physicians' Use of Stop-Smoking Plans to Help Patients Who Are Smokers

Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study